Kings, New York (NY) Biological Products, Except Diagnostic Substances Companies

Featured companies
Luciar
41 Schermerhorn St 325
Brooklyn NY 11201
Et Vacine Technologies Inc
326 Livingston St # A
Brooklyn NY 11217
(347) 554-7483
Bennett Architects and developers: Real Estate Investing-Art-Product Design
250 Park Place 1A
Brooklyn NY 11238
(718) 398-8052

Contact us to find out what our passions are. It's time for the new renaissance movement we call 'SYNTHESIS'
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Luciar
41 Schermerhorn St 325
Brooklyn NY 11201
Realism In Stone Inc
1485 East 5th St.
Brooklyn NY 11230
(917) 841-6383
Next Step Plasma
3424 Quentin Road
Brooklyn NY 11234
Plasma Den 1 Inc
2622 Batchelder St.
Brooklyn NY 11235
(718) 769-1329
Plasma Den 1 Inc
3715 Nostrand Avenue
Brooklyn NY 11235
Venom Productions Inc
621 Lefferts Avenue Apartment C9
Brooklyn NY 11203
(718) 773-4395

Venom Productions Inc is a privately held company in Brooklyn, NY and is a Single Location business.
Whereorg has 11 results under Biological Products, Except Diagnostic Substances Companies in Kings.

Narrow down the browsing criteria below to see more companies.

Select a location for category Biological Products, Except Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020